Prime Medicine, Inc. (PRME) Debt to Equity Ratio
Prime Medicine, Inc. (PRME) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2022-12-31 | 0.09 |
| 2023-12-31 | 0.10 |
| 2024-12-31 | 0.27 |
| 2025-12-31 | 0.96 |
Debt to equity divides total borrowings by total shareholder equity at the period end. Total borrowings are short-term debt plus long-term debt, including capital lease obligations. Non-debt liabilities such as accounts payable and deferred revenue are excluded. A period is omitted when equity is negative, because the ratio is not meaningful then.
Get Prime Medicine, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("PRME", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PRME | $3.08 | -3.00% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 |